Examination of the APOE genotype specificity of these effects revealed that brain insulin metabolism in AD is differentially affected by the various apoE isoforms [146], and that apoE4 impairs neuronal insulin signaling and insulin receptor trafficking in corresponding cellular and animal models [147–150]. Here, INS is linked to Alzheimer disease.